GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (FRA:C6L) » Definitions » Enterprise Value

CellCura ASA (FRA:C6L) Enterprise Value : €0.13 Mil (As of May. 29, 2024)


View and export this data going back to . Start your Free Trial

What is CellCura ASA Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, CellCura ASA's Enterprise Value is €0.13 Mil. CellCura ASA's EBIT for the trailing twelve months (TTM) ended in Jun. 2014 was €-2.33 Mil. Therefore, CellCura ASA's EV-to-EBIT ratio for today is -0.06.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, CellCura ASA's Enterprise Value is €0.13 Mil. CellCura ASA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2014 was €-1.46 Mil. Therefore, CellCura ASA's EV-to-EBITDA ratio for today is -0.09.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, CellCura ASA's Enterprise Value is €0.13 Mil. CellCura ASA's Revenue for the trailing twelve months (TTM) ended in Jun. 2014 was €0.46 Mil. Therefore, CellCura ASA's EV-to-Revenue ratio for today is 0.28.


CellCura ASA Enterprise Value Historical Data

The historical data trend for CellCura ASA's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA Enterprise Value Chart

CellCura ASA Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Enterprise Value
Get a 7-Day Free Trial - - - 4.03 4.22

CellCura ASA Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.34 3.29 4.22 5.16 4.23

Competitive Comparison of CellCura ASA's Enterprise Value

For the Biotechnology subindustry, CellCura ASA's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellCura ASA's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellCura ASA's Enterprise Value distribution charts can be found below:

* The bar in red indicates where CellCura ASA's Enterprise Value falls into.



CellCura ASA Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

CellCura ASA's Enterprise Value for the fiscal year that ended in Dec. 2013 is calculated as

CellCura ASA's Enterprise Value for the quarter that ended in Jun. 2014 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellCura ASA  (FRA:C6L) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

CellCura ASA's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.130/-2.328
=-0.06

CellCura ASA's current Enterprise Value is €0.13 Mil.
CellCura ASA's EBIT for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.33 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

CellCura ASA's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=0.130/-1.462
=-0.09

CellCura ASA's current Enterprise Value is €0.13 Mil.
CellCura ASA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.46 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

CellCura ASA's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=0.130/0.46
=0.28

CellCura ASA's current Enterprise Value is €0.13 Mil.
CellCura ASA's Revenue for the trailing twelve months (TTM) ended in Jun. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellCura ASA Enterprise Value Related Terms

Thank you for viewing the detailed overview of CellCura ASA's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


CellCura ASA (FRA:C6L) Business Description

Traded in Other Exchanges
N/A
Address
Unionsgata 18, Skien, NOR, 3732
CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.

CellCura ASA (FRA:C6L) Headlines

No Headlines